S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
Log in

OTCMKTS:MYDPDougherty's Pharmacy Stock Price, Forecast & News

$0.0080
0.00 (-12.09 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01▼
$0.01
50-Day Range
$0.01
MA: $0.01▼
$0.01
52-Week Range
$0.01
Now: $0.01▼
$0.07
Volume310 shs
Average Volume42,970 shs
Market Capitalization$184,784.00
P/E RatioN/A
Dividend YieldN/A
Beta4.37
Dougherty's Pharmacy, Inc., an investment firm, focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1998 and is based in Dallas, Texas.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.46 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Drug stores & proprietary stores
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MYDP
Previous Symbol
CUSIPN/A
CIK1080029
Webwww.doughertys.com
Phone972-250-0945

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$36.05 million
Price / Sales0.01
Cash FlowN/A
Price / Cash FlowN/A
Book Value($0.08) per share
Price / Book-0.10

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees75
Outstanding Shares23,098,000
Market Cap$184,784.00
Next Earnings DateN/A
OptionableNot Optionable
$0.0080
0.00 (-12.09 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MYDP News and Ratings via Email

Sign-up to receive the latest news and ratings for MYDP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Dougherty's Pharmacy (OTCMKTS:MYDP) Frequently Asked Questions

How has Dougherty's Pharmacy's stock been impacted by COVID-19 (Coronavirus)?

Dougherty's Pharmacy's stock was trading at $0.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MYDP shares have decreased by 20.0% and is now trading at $0.0080.
View which stocks have been most impacted by Coronavirus.

How were Dougherty's Pharmacy's earnings last quarter?

Dougherty's Pharmacy Inc (OTCMKTS:MYDP) posted its quarterly earnings results on Tuesday, August, 14th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $9.17 million for the quarter.
View Dougherty's Pharmacy's earnings history.

Has Dougherty's Pharmacy been receiving favorable news coverage?

News headlines about MYDP stock have trended very positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Dougherty's Pharmacy earned a coverage optimism score of 4.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days.
View the latest news about Dougherty's Pharmacy.

Who are some of Dougherty's Pharmacy's key competitors?

Some companies that are related to Dougherty's Pharmacy include CVS Health (CVS), Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD) and HealthWarehouse.com (HEWA).
View all competitors.

What other stocks do shareholders of Dougherty's Pharmacy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dougherty's Pharmacy investors own include Zynerba Pharmaceuticals (ZYNE), Armstrong World Industries (AWI), Bristol-Myers Squibb (BMY), National Vision (EYE), Floor & Decor (FND), Toronto-Dominion Bank (TD), Atlassian (TEAM), Altice USA (ATUS), Amneal Pharmaceuticals (AMRX) and Alta Mesa Resources (AMR).

Who are Dougherty's Pharmacy's key executives?

Dougherty's Pharmacy's management team includes the following people:
  • Mr. James C. Leslie CPA, CPA, Chairman & Sec. (Age 64)
  • Mr. Stewart I. Edington, Pres, CEO, Interim CFO & Director (Age 71)
  • Ms. Katherine Burrow, Managing Director of Bus. Devel.
  • Ms. Susan K. Olson, Sec.
  • Ms. Robin Bruce, Controller

What is Dougherty's Pharmacy's stock symbol?

Dougherty's Pharmacy trades on the OTCMKTS under the ticker symbol "MYDP."

How do I buy shares of Dougherty's Pharmacy?

Shares of MYDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Dougherty's Pharmacy's stock price today?

One share of MYDP stock can currently be purchased for approximately $0.01.

How big of a company is Dougherty's Pharmacy?

Dougherty's Pharmacy has a market capitalization of $184,784.00 and generates $36.05 million in revenue each year. Dougherty's Pharmacy employs 75 workers across the globe.

What is Dougherty's Pharmacy's official website?

The official website for Dougherty's Pharmacy is www.doughertys.com.

How can I contact Dougherty's Pharmacy?

Dougherty's Pharmacy's mailing address is 5924 ROYAL LANE SUITE 250, DALLAS TX, 75230. The company can be reached via phone at 972-250-0945 or via email at [email protected]

This page was last updated on 8/7/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.